类风湿关节炎的心血管风险管理：我们仍在等待第一步吗？
Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?
作者信息
Peters Mike J L, Nurmohamed Michael T
出版信息
Arthritis Res Ther. 2013 Mar 19;15(2):111. doi: 10.1186/ar4185.
Rheumatoid arthritis (RA) is associated with a similar cardiovascular risk to that in diabetes, and therefore cardiovascular risk management (CV-RM) - that is, identification and treatment of cardiovascular risk factors (CRFs) - is mandatory. However, whether and to what extent this is done in daily clinical practice is unknown. In a retrospective cohort investigation, CV-RM was therefore compared between rheumatologists and primary care physicians (PCPs). Remarkably, CRFs in RA were less frequently identified and managed by rheumatologists in comparison with PCPs. In addition, PCPs assessed CRFs less frequently in RA than in diabetes. Obviously, there is a clear need for improvement of CV-RM in RA and this should be a joint effort from the rheumatologist and the PCP.
类风湿关节炎（RA）与糖尿病患者具有相似的心血管疾病风险，因此心血管风险管理（CV-RM）——即识别和治疗心血管危险因素（CRF）——是必不可少的。然而，在日常临床实践中是否以及在何种程度上进行了这种管理尚不清楚。因此，在一项回顾性队列研究中，对风湿病学家和初级保健医生（PCP）的CV-RM进行了比较。值得注意的是，与PCP相比，风湿病学家对RA患者CRF的识别和管理频率较低。此外，PCP对RA患者CRF的评估频率低于对糖尿病患者的评估频率。显然，RA患者的CV-RM有明显的改进需求，这需要风湿病学家和PCP共同努力。
Zotero 插件